Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Active Alcoholic Smokers
NCT01347112Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in tobacco dependence, alcohol dependence, sponsored by Mayo Clinic. Started Jun 2011; status: completed.
02
Drugs
varenicline
03
Conditions
tobacco dependencealcohol dependence
Beyond the preview
Go deeper on NCT01347112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347112.